Почетна › Не-Хочкин лимфом › Њујорк

Клинички испитувања за Не-Хочкин лимфом во Њујорк

40 студии за Не-Хочкин лимфом бараат учесници на локации во Њујорк.

Градови во Њујорк

Официјален текст на студијата (англиски)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Roswell Park Comprehensive Cancer Center, Buffalo
Columbia University Medical Center, New York
Weill Cornell Medical College Newyork Presbyterian Hospital, New York
и уште 1

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT05006716

Epco, Zanu, Ritux for R/R FL or MZL

Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06563596

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Northwell Health Monter Cancer Center, Lake Success
Northern Westchester Hospital, Mount Kisco
Cohen Children's Medical Center, New Hyde Park
и уште 4

Се регрутираФаза 2

Возраст 12 и постари · Сите полови · Ажурирано 22.9.2026 · NCT02693535

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

New York University (NYU) Clinical Cancer Center, New York
Weill Cornell Medicine, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Columbia University, New York
University of Rochester, Rochester

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07226843

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 15.9.2026 · NCT07195916

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

Cornell, New York

Се регрутираФаза 1

Возраст од 18 до 100 · Сите полови · Ажурирано 15.9.2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Research Site, New York

Се регрутираФаза 1/2

Возраст 12 и постари · Сите полови · Ажурирано 14.9.2026 · NCT06137144

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Local Institution - 0037, New York
Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT06090539

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Research Site, New York

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT06526793

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

New York Oncology Hematology, P.C., Albany
Hematology Oncology Associates of Central New York, East Syracuse

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 11.9.2026 · NCT06806033

Cord Blood Transplant in Adults With Blood Cancers

Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 2

Возраст од 21 до 65 · Сите полови · Ажурирано 11.9.2026 · NCT05884333

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

Rochester Skin Lymphoma Medical Group. PLLC, Rochester

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT06854653

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Columbia University Irving Medical Center/New York Presbyterian Hospital, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT03666000

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medicine - New York Presbyterian Hospital, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07082803

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Clinical Trial Site, New York
Clinical Trial Site, New York

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT06393738

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Research Site, New York

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 28.8.2026 · NCT07123454

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Roswell Park Comprehensive Cancer Center, Buffalo
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT05826535

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Се регрутираФаза 1/2

12 Months – 30 Years · Сите полови · Ажурирано 25.8.2026 · NCT04851119

A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Consent only), Harrison
Weill Cornell Medical Center (Data Analysis Only), New York
и уште 2

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 6.8.2026 · NCT07249528

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

Се регрутираФаза 1/2

Возраст од 13 до 90 · Сите полови · Ажурирано 6.8.2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Roswell Park Comprehensive Cancer Center, Buffalo

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 4.8.2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 13.7.2026 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center - Moses Campus, The Bronx

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 10.7.2026 · NCT05077527

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Roswell Park Cancer Institute, Buffalo
North Shore University Hospital, Lake Sucess
Cohen Children's Medical Center of New York, New Hyde
и уште 9

Се регрутираНабљудувачка студија

Сите возрасти · Сите полови · Ажурирано 6.7.2026 · NCT01351545

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

Се регрутираФаза 2

До возраст 26 · Сите полови · Ажурирано 14.5.2026 · NCT07566377

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Roswell Park Comprehensive Cancer Center, Buffalo
Mt Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 1/2

Возраст 18 и постари · Сите полови · Ажурирано 16.4.2026 · NCT03328078

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Glens Falls Hospital, Glens Falls
Queens Hospital Center, Jamaica
Montefiore Medical Center-Einstein Campus, The Bronx
и уште 1

Се регрутираНабљудувачка студија

Возраст 18 и постари · Сите полови · Ажурирано 17.3.2026 · NCT06418204

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

Memorial Sloan Kettering Cancer Center, New York

Се регрутираФаза 2

До возраст 21 · Сите полови · Ажурирано 13.3.2026 · NCT04644016

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

Icahn School of Medicine at Mount Sinai, New York

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 13.3.2026 · NCT06510361

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Cayuga Cancer Center, Ithaca
Northwell Health, Lake Success
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York
и уште 2

Се регрутираФаза 4

Возраст 18 и постари · Сите полови · Ажурирано 2.3.2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Northwell Health, Lake Success
Memorial Sloan-Kettering Cancer Center (MSKCC) - New York, New York

Се регрутираФаза 4

Возраст 18 и постари · Сите полови · Ажурирано 2.3.2026 · NCT06876662

Study of SGR-1505 in Mature B-Cell Neoplasms

Roswell Park Comprehensive Cancer Center, Buffalo
Weill Cornell, New York
Montefiore Medical Center, The Bronx

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 13.2.2026 · NCT05544019

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Memorial Sloan Kettering Cancer Center, New York

Се регрутираРана фаза 1

Возраст 18 и постари · Сите полови · Ажурирано 5.2.2026 · NCT05093335

Amping up With PemJAK

Columbia University Irving Medical Center, New York

Се регрутираФаза 2

Возраст од 18 до 95 · Сите полови · Ажурирано 16.12.2025 · NCT07283822

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Optum Medical Care PC, Westbury

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 10.12.2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
и уште 2

Се регрутираНабљудувачка студија

Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

New York Medical College, Valhalla

Се регрутираФаза 2

Возраст од 3 до 31 · Сите полови · Ажурирано 8.8.2025 · NCT02393157

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

New York Medical College, Valhalla

Се регрутираФаза 2

1 Day – 30 Years · Сите полови · Ажурирано 8.8.2025 · NCT04099966

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

New York Medical College, Vallhala

Се регрутираФаза 2

Возраст од 3 до 39 · Сите полови · Ажурирано 13.6.2025 · NCT05253495

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.